DaVita (DVA) Stock Insights
DVA$192.58+8.65 +4.70%
$12.29B
Market Cap
15.82
P/E
12.99
Forward P/E
62
Score
DaVita (DVA) Stock Insights
DVA price $192.58 +8.65 +4.70%
- Ticker
- DVA
- Price
- $192.58
- Change
- +8.65 +4.70%
- Market cap ?
- $12.29B
- P/E ?
- 15.82
- Forward P/E ?
- 12.99
- Dividend yield ?
- 0.00%
- Beta ?
- 0.80
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Stocklytics score
- 62
- Value
- 75
- Quality
- 53
- Growth
- 58
Stocklytics score rationale: value 75, quality 53, growth 58.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 14745105000 | 10876634000 | 11404851000 | 11388479000 | 11550604000 | 11618797000 | 11609894000 | 12140147000 | 12815550000 | 13643069000 |
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic…
Fair value
DVA fair value $425.70. Price $192.58. Price is 55% below fair value.
Below fair value, and cheaper than usual. A larger discount than on 96% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 1.61B. Growth 17.16%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 63.80M. Net debt 14.29B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-29 | — | 3.57 | — | 3.52B |
| 2026-08-04 | 4.02 | 3.88 | 3.55B | 3.50B |
| 2026-05-05 | 2.87 | 2.41 | 3.42B | 3.36B |
| 2026-02-02 | 3.40 | 3.24 | 3.62B | 3.51B |
| 2025-10-29 | 2.51 | 3.17 | 3.42B | 3.43B |
| 2025-08-05 | 2.95 | 2.70 | 3.38B | 3.44B |
| 2025-05-12 | 2.00 | 1.95 | 3.22B | 3.21B |
| 2025-02-13 | 2.24 | 2.14 | 3.29B | 3.27B |
| 2024-10-29 | 2.59 | 2.72 | 3.26B | 3.27B |
| 2024-08-06 | 2.50 | 2.54 | 3.19B | 3.15B |
| 2024-05-02 | 2.26 | 1.95 | 3.07B | 3.03B |
| 2024-02-13 | 1.62 | 1.59 | 3.15B | 3.01B |
| 2023-11-07 | 2.62 | 2.02 | 3.12B | 3.02B |
| 2023-08-03 | 1.91 | 1.69 | 3.00B | 2.95B |
| 2023-05-08 | 1.25 | 1.15 | 2.87B | 2.84B |
| 2023-02-22 | 1.11 | 0.88 | 2.92B | 2.93B |
| 2022-10-28 | 1.45 | 1.65 | 2.95B | 2.98B |
| 2022-08-01 | 2.30 | 2.09 | 2.93B | 2.93B |
| 2022-05-05 | 1.61 | 1.87 | 2.82B | 2.89B |
| 2022-02-10 | 2.02 | 1.80 | 2.94B | 2.91B |
| 2021-10-28 | 2.36 | 2.25 | 2.94B | 2.93B |
| 2021-08-03 | 2.64 | 2.17 | 2.92B | 2.87B |
| 2021-04-29 | 2.09 | 1.82 | 2.82B | 2.83B |
| 2021-02-11 | 1.67 | 1.87 | 2.91B | 2.93B |
| 2020-10-29 | 1.80 | 1.49 | 2.92B | 2.34B |
| 2020-07-30 | 1.95 | 1.30 | 2.88B | 1.92B |
| 2020-05-05 | 1.83 | 1.47 | 2.84B | 2.28B |
| 2020-02-10 | 1.86 | 1.66 | 2.90B | 2.59B |
| 2019-11-05 | 1.53 | 1.23 | 2.90B | 2.35B |
| 2019-08-01 | 1.22 | 1.11 | 2.84B | 2.59B |
| 2019-05-07 | 0.91 | 0.93 | 2.74B | 2.80B |
| 2019-02-13 | 0.90 | 0.89 | 2.82B | 2.82B |
| 2018-11-07 | 0.56 | 0.89 | 2.85B | 4.42B |
| 2018-08-01 | 1.05 | 0.97 | 2.89B | 2.67B |
| 2018-05-03 | 1.05 | 0.93 | 2.85B | 2.52B |
| 2018-02-13 | 0.92 | 0.91 | 2.78B | 2.84B |
| 2017-11-07 | 0.81 | 0.94 | 3.92B | 3.21B |
| 2017-08-01 | 0.92 | 0.90 | 3.88B | 2.64B |
| 2017-05-02 | 0.79 | 0.82 | 3.70B | 2.73B |
| 2017-02-16 | 0.98 | 0.91 | 3.72B | 298.91M |
Dividends
Yield 0.00%. Payout ratio 17.69%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 18% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-22 | Maughan David Paul | Sell | 7.50K | $182.34 | 1.37M |
| 2026-08-15 | Hollar Jason M. | Buy | 278 | — | — |
| 2026-08-15 | DESOER BARBARA J | Buy | 278 | — | — |
| 2026-08-15 | Schechter Adam H | Buy | 278 | — | — |
| 2026-08-15 | Moore Gregory J. | Buy | 278 | — | — |
| 2026-08-15 | Pullin Dennis W | Buy | 278 | — | — |
| 2026-08-15 | Schoppert Wendy Lee | Buy | 278 | — | — |
| 2026-08-15 | Arway Pamela M | Buy | 278 | — | — |
| 2026-08-15 | YALE PHYLLIS R | Buy | 278 | — | — |
| 2026-07-31 | BERKSHIRE HATHAWAY INC | Sell | 182.98K | $199.55 | 36.51M |
| 2026-06-16 | Rodriguez Javier | Sell | 39.41K | $209.28 | 8.25M |
| 2026-06-15 | Waters Kathleen Alyce | Sell | 8.95K | $207.84 | 1.86M |
| 2026-06-15 | Waters Kathleen Alyce | Sell | 6.46K | $209.17 | 1.35M |
| 2026-06-15 | Rodriguez Javier | Sell | 30.00K | $209.50 | 6.29M |
| 2026-05-26 | YALE PHYLLIS R | Sell | 5.04K | — | — |
| 2026-05-15 | Pullin Dennis W | Buy | 250 | — | — |
| 2026-05-15 | Moore Gregory J. | Buy | 250 | — | — |
| 2026-05-15 | Schoppert Wendy Lee | Buy | 250 | — | — |
| 2026-05-15 | Arway Pamela M | Buy | 250 | — | — |
| 2026-05-15 | YALE PHYLLIS R | Buy | 250 | — | — |
| 2026-05-15 | DESOER BARBARA J | Buy | 250 | — | — |
| 2026-05-15 | Schechter Adam H | Buy | 250 | — | — |
| 2026-05-15 | Hollar Jason M. | Buy | 250 | — | — |
| 2026-05-15 | HEARTY JAMES O | Sell | 15.00K | $193.98 | 2.91M |
| 2026-05-14 | HEARTY JAMES O | Buy | 5.78K | $110.63 | 639.88K |
| 2026-05-14 | HEARTY JAMES O | Sell | 3.23K | $198.10 | 640.06K |
| 2026-05-14 | HEARTY JAMES O | Sell | 1.12K | $198.10 | 221.28K |
| 2026-05-14 | HEARTY JAMES O | Sell | 5.78K | $110.63 | 639.88K |
| 2026-05-12 | Maughan David Paul | Sell | 13.46K | $199.25 | 2.68M |
| 2026-05-11 | Maughan David Paul | Sell | 7.07K | $199.15 | 1.41M |
| 2026-05-07 | ACKERMAN JOEL | Sell | 51.47K | $192.10 | 9.89M |
| 2026-05-06 | HEARTY JAMES O | Sell | 2.18K | $174.87 | 381.92K |
| 2026-05-01 | BERKSHIRE HATHAWAY INC | Sell | 1.22M | $149.84 | 182.86M |
| 2026-03-15 | Arway Pamela M | Buy | 332 | — | — |
| 2026-03-15 | DESOER BARBARA J | Buy | 332 | — | — |
| 2026-03-15 | Maughan David Paul | Buy | 5.31K | — | — |
| 2026-03-15 | Maughan David Paul | Sell | 5.34K | $150.72 | 804.69K |
| 2026-03-15 | Maughan David Paul | Sell | 7.77K | $150.72 | 1.17M |
| 2026-03-15 | Maughan David Paul | Buy | 14.35K | $150.72 | 2.16M |
| 2026-03-15 | YALE PHYLLIS R | Buy | 332 | — | — |
| 2026-03-15 | Rodriguez Javier | Buy | 20.90K | — | — |
| 2026-03-15 | Rodriguez Javier | Buy | 56.51K | $150.72 | 8.52M |
| 2026-03-15 | Pullin Dennis W | Buy | 332 | — | — |
| 2026-03-15 | Hollar Jason M. | Buy | 332 | — | — |
| 2026-03-15 | BERRY CHRISTOPHER MICHAEL | Buy | 3.65K | — | — |
| 2026-03-15 | ACKERMAN JOEL | Buy | 5.71K | — | — |
| 2026-03-15 | ACKERMAN JOEL | Sell | 3.36K | $150.72 | 506.72K |
| 2026-03-15 | ACKERMAN JOEL | Sell | 33.69K | $150.72 | 5.08M |
| 2026-03-15 | ACKERMAN JOEL | Sell | 5.76K | $150.72 | 868.90K |
| 2026-03-15 | ACKERMAN JOEL | Buy | 15.43K | $150.72 | 2.33M |
| 2026-03-15 | Schechter Adam H | Buy | 332 | — | — |
| 2026-03-15 | Moore Gregory J. | Buy | 332 | — | — |
| 2026-03-15 | Waters Kathleen Alyce | Buy | 3.19K | — | — |
| 2026-03-15 | Waters Kathleen Alyce | Sell | 2.46K | $150.72 | 370.32K |
| 2026-03-15 | Waters Kathleen Alyce | Sell | 26.12K | $150.72 | 3.94M |
| 2026-03-15 | Waters Kathleen Alyce | Sell | 940 | $150.72 | 141.68K |
| 2026-03-15 | Waters Kathleen Alyce | Sell | 4.35K | $150.72 | 655.33K |
| 2026-03-15 | Waters Kathleen Alyce | Buy | 8.61K | $150.72 | 1.30M |
| 2026-03-15 | HEARTY JAMES O | Buy | 1.13K | — | — |
| 2026-03-15 | HEARTY JAMES O | Sell | 769 | $150.72 | 115.90K |
| 2026-03-15 | HEARTY JAMES O | Sell | 8.98K | $150.72 | 1.35M |
| 2026-03-15 | HEARTY JAMES O | Sell | 300 | $150.72 | 45.22K |
| 2026-03-15 | HEARTY JAMES O | Sell | 1.52K | $150.72 | 229.85K |
| 2026-03-15 | HEARTY JAMES O | Buy | 3.05K | $150.72 | 459.70K |
| 2026-03-15 | Schoppert Wendy Lee | Buy | 332 | — | — |
| 2026-03-10 | HEARTY JAMES O | Buy | 20.53K | — | — |
| 2026-03-10 | HEARTY JAMES O | Buy | 1.76K | — | — |
| 2026-03-10 | ACKERMAN JOEL | Buy | 66.00K | — | — |
| 2026-03-10 | ACKERMAN JOEL | Buy | 6.58K | — | — |
| 2026-03-10 | Waters Kathleen Alyce | Buy | 51.33K | — | — |
| 2026-03-10 | Waters Kathleen Alyce | Buy | 4.83K | — | — |
| 2026-02-06 | Waters Kathleen Alyce | Buy | 8.08K | $108.93 | 880.05K |
| 2026-02-06 | Waters Kathleen Alyce | Sell | 5.90K | $149.22 | 880.10K |
| 2026-02-06 | Waters Kathleen Alyce | Sell | 817 | $149.22 | 121.91K |
| 2026-02-06 | Waters Kathleen Alyce | Sell | 8.08K | $108.93 | 880.05K |
| 2026-02-06 | ACKERMAN JOEL | Buy | 44.06K | $108.93 | 4.80M |
| 2026-02-06 | ACKERMAN JOEL | Sell | 32.17K | $149.22 | 4.80M |
| 2026-02-06 | ACKERMAN JOEL | Sell | 5.10K | $149.22 | 761.02K |
| 2026-02-06 | ACKERMAN JOEL | Sell | 44.06K | $108.93 | 4.80M |
| 2026-01-29 | BERKSHIRE HATHAWAY INC | Sell | 1.66M | $120.56 | 199.94M |
| 2025-12-04 | HEARTY JAMES O | Buy | 5.88K | $108.93 | 639.96K |
| 2025-12-04 | HEARTY JAMES O | Sell | 5.41K | $118.25 | 639.97K |
| 2025-12-04 | HEARTY JAMES O | Sell | 203 | $118.25 | 24.00K |
| 2025-12-04 | HEARTY JAMES O | Sell | 5.88K | $108.93 | 639.96K |
| 2025-11-15 | YALE PHYLLIS R | Buy | 411 | — | — |
| 2025-11-15 | Schoppert Wendy Lee | Buy | 411 | — | — |
| 2025-11-15 | Schechter Adam H | Buy | 411 | — | — |
| 2025-11-15 | Pullin Dennis W | Buy | 411 | — | — |
| 2025-11-15 | Moore Gregory J. | Buy | 411 | — | — |
| 2025-11-15 | Hollar Jason M. | Buy | 411 | — | — |
| 2025-11-15 | DESOER BARBARA J | Buy | 411 | — | — |
| 2025-11-15 | Arway Pamela M | Buy | 411 | — | — |
| 2025-11-15 | Rodriguez Javier | Sell | 5.17K | $121.55 | 627.81K |
| 2025-10-27 | BERKSHIRE HATHAWAY INC | Sell | 401.51K | $135.36 | 54.35M |
| 2025-09-22 | Maughan David Paul | Sell | 7.50K | $130.16 | 976.33K |
| 2025-08-15 | Schechter Adam H | Buy | 369 | — | — |
| 2025-08-15 | YALE PHYLLIS R | Buy | 369 | — | — |
| 2025-08-15 | DESOER BARBARA J | Buy | 369 | — | — |
| 2025-08-15 | Hollar Jason M. | Buy | 369 | — | — |
| 2025-08-15 | Moore Gregory J. | Buy | 369 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 665, holders +54 vs prior quarter. Ownership 91.66%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BERKSHIRE HATHAWAY INC | 28.88M | -1.22M | -4.05% | 6.43B |
| BLACKROCK, INC. | 2.46M | -305.76K | -11.05% | 547.52M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.10M | -78.80K | -3.61% | 467.53M |
| MORGAN STANLEY | 1.60M | -64.33K | -3.86% | 356.35M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.38M | -101.69K | -6.87% | 306.56M |
| STATE STREET CORP | 1.32M | -28.72K | -2.12% | 294.35M |
| INVESCO LTD. | 1.21M | -255.96K | -17.44% | 269.63M |
| DIMENSIONAL FUND ADVISORS LP | 1.14M | -7.62K | -0.67% | 253.13M |
| NEUBERGER BERMAN GROUP LLC | 925.58K | 393.49K | +73.95% | 205.76M |
| LSV ASSET MANAGEMENT | 908.39K | -22.67K | -2.43% | 202.10M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 889.08K | -221.07K | -19.91% | 197.80M |
| GEODE CAPITAL MANAGEMENT, LLC | 853.60K | -86.18K | -9.17% | 189.56M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 733.40K | 689.69K | +1577.88% | 163.17M |
| GATES CAPITAL MANAGEMENT, INC. | 688.14K | -34.87K | -4.82% | 153.10M |
| BANK OF AMERICA CORP /DE/ | 652.00K | 410.94K | +170.47% | 145.06M |
| D. E. SHAW & CO., INC. | 640.83K | 136.19K | +26.99% | 142.57M |
| AQR CAPITAL MANAGEMENT LLC | 587.76K | 177.74K | +43.35% | 128.13M |
| GOLDMAN SACHS GROUP INC | 463.38K | 15.96K | +3.57% | 103.09M |
| BANK OF NEW YORK MELLON CORP | 454.55K | -2.95K | -0.64% | 101.13M |
| NORDEA INVESTMENT MANAGEMENT AB | 395.69K | 10.98K | +2.85% | 87.43M |
| NORTHERN TRUST CORP | 382.04K | -31.19K | -7.55% | 85.00M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 365.57K | 365.57K | New | 81.33M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 365.57K | -18.07K | -4.71% | 81.33M |
| NORGES BANK | 344.42K | 344.42K | New | 76.63M |
| ACADIAN ASSET MANAGEMENT LLC | 331.14K | 262.96K | +385.64% | 73.64M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2010 | Other Segments: 374497000.0 |
| FY2011 | Other Segments: 514181000.0 |
| FY2012 | Other Segments: 642472000.0, U S Dialysis And Related Lab Services: 7316818000.0 |
| FY2013 | Other Segments: 694763000.0, U S Dialysis And Related Lab Services: 8032772000.0 |
| FY2014 | U S Dialysis And Related Lab Services: 8550201000.0 |
| FY2015 | U S Dialysis And Related Lab Services: 9033991000.0 |
| FY2016 | U S Dialysis And Related Lab Services: 9551422000.0 |
| FY2017 | Other Segments: 1596347000.0, U S Dialysis And Related Lab Services: 9822298000.0 |
| FY2018 | Other Segments: 1196088000.0, U S Dialysis And Related Lab Services: 10366996000.0 |
| FY2019 | Other Segments: 971928000.0, U S Dialysis And Related Lab Services: 10562906000.0 |
| FY2020 | Other Segments: 1052698000.0, U S Dialysis And Related Lab Services: 10659935000.0 |
| FY2021 | Other Segments: 1046924000.0, U S Dialysis And Related Lab Services: 10666963000.0 |
| FY2022 | Other Segments: 1101326000.0, U S Dialysis And Related Lab Services: 10599809000.0 |
| FY2023 | Other Segments: 1299223000.0, U S Dialysis And Related Lab Services: 10936998000.0 |
| FY2024 | U S Dialysis And Related Lab Services: 11318970000.0 |
| FY2025 | U S Dialysis And Related Lab Services: 11731986000.0 |
| Period | Value |
|---|---|
| Q1 2014 | International: 23246000.0, U S: 206955000.0 |
| Q2 2014 | International: 24035000.0, U S: 222716000.0 |
| Q3 2014 | U S: 240770000.0 |
Insights · Dividends · Forecast · Financials · Learn